Jiasen Ma, Ph.D.

  1. Radiation Oncology Medical Physicist
  1. Xu H, Lin J, Woicik A, Liu Z, Ma J, Zhang S, Poon H, Wang L, Wang S. Pisces: A multi-modal data augmentation approach for drug combination synergy prediction. Cell Genom. 2025 Jul 9; 5 (7):100892 Epub 2025 June 03
    View PubMed
  2. Ma J, Dragojevic S, Remmes NB, Mendelson NL, Kloeber JA, Ebner DK, Wu Z, Gunn HJ, Merrell KW, Hallemeier CL, Haddock MG, Jethwa KR, Lou Z, Mutter RW, Callaghan CM. Linear energy transfer optimized proton therapy for rectal cancer. Radiother Oncol. 2025 Jun; 207:110850 Epub 2025 Mar 16
    View PubMed
  3. Gergelis KR, Bai M, Ma J, Routman DM, Stish BJ, Davis BJ, Pisansky TM, Whitaker TJ, Choo R. Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate Cancer. Curr Oncol. 2025 Apr 2; 32 (4) Epub 2025 Apr 02
    View PubMed
  4. Kwapnoski Z, Clarey D, Ma J, Schmidt CM, Wysong A. Cutaneous Angiosarcoma Subtypes: A Quantitative Systematic Review of Demographics, Treatments, and Outcomes Within Published Patient-Level Cases. Dermatol Surg. 2024 Jul 1; 50 (7):620-626 Epub 2024 Mar 26
    View PubMed
  5. Gao RW, Ma J, Pisansky TM, Kruse JJ, Stish BJ, Kowalchuk RO, McMenomy BP, Waddle MR, Phillips RM, Choo R, Davis BJ. Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer. Int J Part Ther. 2024 Jun; 12:100015 Epub 2024 Apr 24
    View PubMed
  6. Crane HM, Nance RM, Ruderman SA, Haidar L, Tenforde MW, Heckbert SR, Budoff MJ, Hahn AW, Drumright LN, Ma J, Mixson LS, Lober WB, Barnes GS, McReynolds J, Attia EF, Peter I, Moges T, Bamford L, Cachay E, Mathews WC, Christopolous K, Hunt PW, Napravnik S, Keruly J, Moore RD, Burkholder G, Willig AL, Lindstrom S, Whitney BM, Saag MS, Kitahata MM, Crothers KA, Delaney JAC. Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United States. J Acquir Immune Defic Syndr. 2024 Feb 1; 95 (2):207-214
    View PubMed
  7. Ruderman SA, Odden MC, Webel AR, Fitzpatrick AL, Crane PK, Nance RM, Drumright LN, Whitney BM, Mixson LS, Ma J, Willig AL, Haidar L, Eltonsy S, Mayer KH, O'Cleirigh C, Cropsey KL, Eron JJ, Napravnik S, Greene M, McCaul M, Chander G, Cachay E, Lober WB, Kritchevsky SB, Austad S, Landay A, Pandya C, Cartujano-Barrera F, Saag MS, Kamen C, Hahn AW, Kitahata MM, Delaney JAC, Crane HM. Tobacco Smoking and Pack-Years Are Associated With Frailty Among People With HIV. J Acquir Immune Defic Syndr. 2023 Oct 1; 94 (2):135-142
    View PubMed
  8. Drumright LN, Nance RM, Ruderman SA, Ma J, Whitney BM, Hahn A, Fredericksen RJ, Luu B, Lober WB, Moore RD, Budoff MJ, Keruly JC, Christopoulos K, Puryear S, Willig A, Cropsey K, Mathews WC, Cachay E, Bamford L, Eron JJ, Napravnik S, Mayer KH, O'Cleirigh C, Mccaul ME, Chander G, Feinstein MJ, Saag MS, Kitahata MM, Heckbert SR, Crane HM, Delaney JAC. Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV. HIV Med. 2023 Jun; 24 (6):703-715 Epub 2023 Feb 28
    View PubMed
  9. Ruderman SA, Nance RM, Drumright LN, Whitney BM, Hahn AW, Ma J, Haidar L, Eltonsy S, Mayer KH, Eron JJ, Greene M, Mathews WC, Webel A, Saag MS, Willig AL, Kamen C, McCaul M, Chander G, Cachay E, Lober WB, Pandya C, Cartujano-Barrera F, Kritchevsky SB, Austad SN, Landay A, Kitahata MM, Crane HM, Delaney JAC. Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIV. AIDS. 2023 May 1; 37 (6):967-975 Epub 2023 Jan 31
    View PubMed
  10. Hahn AW, Ruderman SA, Nance RM, Whitney BW, Eltonsy S, Haidar L, Delaney JAC, Drumright LN, Ma J, Mayer KH, 'Cleirigh CO, Napravnik S, Eron JJ, Christopoulos K, Bamford L, Cachay E, Jacobson JM, Willig A, Cropsey K, Chander G, Crane HM, Fredericksen RJ. Vaporized Nicotine (E-Cigarette) and Tobacco Smoking Among People With HIV: Use Patterns and Associations With Depression and Panic Symptoms. J Acquir Immune Defic Syndr. 2023 Mar 1; 92 (3):197-203
    View PubMed
  11. Crane HM, Ruderman SA, Whitney BM, Nance RM, Drumright LN, Webel AR, Willig AL, Saag MS, Christopoulos K, Greene M, Hahn AW, Eron JJ, Napravnik S, Mathews WC, Chander G, McCaul ME, Cachay ER, Mayer KH, Landay A, Austad S, Ma J, Kritchevsky SB, Pandya C, Achenbach C, Cartujano-Barrera F, Kitahata M, Delaney JA, Kamen C, Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort Study. Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatment. Drug Alcohol Depend. 2022 Nov 1; 240:109649 Epub 2022 Sept 30
    View PubMed
  12. Ma J, Nance RM, Delaney JAC, Whitney BM, Bamford L, Gravett RM, Moore RD, Napravnik S, Mayer KH, Jacobson JM, Christopoulos K, Burkholder GA, Keruly J, Eron JJ, Martin J, Cachay ER, Saag MS, Crane HM, Kitahata MM. Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort. Clin Infect Dis. 2022 Sep 10; 75 (4):715-718
    View PubMed
  13. Bey A, Ma J, Furutani KM, Herman MG, Johnson JE, Foote RL, Beltran CJ. Nuclear Fragmentation Imaging for Carbon-Ion Radiation Therapy Monitoring: an In Silico Study. Int J Part Ther. 2022 Spring; 8 (4):25-36 Epub 2021 Sept 01
    View PubMed
  14. Martinez-Zayas G, Almeida FA, Yarmus L, Steinfort D, Lazarus DR, Simoff MJ, Saettele T, Murgu S, Dammad T, Duong DK, Mudambi L, Filner JJ, Molina S, Aravena C, Thiboutot J, Bonney A, Rueda AM, Debiane LG, Hogarth DK, Bedi H, Deffebach M, Sagar AS, Cicenia J, Yu DH, Cohen A, Frye L, Grosu HB, Gildea T, Feller-Kopman D, Casal RF, Machuzak M, Arain MH, Sethi S, Eapen GA, Lam L, Jimenez CA, Ribeiro M, Noor LZ, Mehta A, Song J, Choi H, Ma J, Li L, Ost DE. Predicting Lymph Node Metastasis in Non-small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models. Chest. 2021 Sep; 160 (3):1108-1120 Epub 2021 Apr 28
    View PubMed
  15. Hunzeker A, Mundy DW, Ma J, Mullikin TC, Foote RL. Intensity-Modulated Proton Therapy (IMPT) Treatment of Angiosarcoma of the Face and Scalp. Int J Part Ther. 2021 Summer; 8 (1):304-310 Epub 2021 June 25
    View PubMed
  16. Ma J, Wan Chan Tseung HS, Courneyea L, Beltran C, Herman MG, Remmes NB. Robust radiobiological optimization of ion beam therapy utilizing Monte Carlo and microdosimetric kinetic model. Phys Med Biol. 2020 Jul 31; 65 (15):155020 Epub 2020 July 31
    View PubMed
  17. Chen L, Marsiglia WM, Chen H, Katigbak J, Erdjument-Bromage H, Kemble DJ, Fu L, Ma J, Sun G, Zhang Y, Liang G, Neubert TA, Li X, Traaseth NJ, Mohammadi M. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nat Chem Biol. 2020 Mar; 16 (3):267-277 Epub 2020 Jan 20
    View PubMed
  18. Ahn JK, Beckford B, Beechert J, Bryant K, Campbell M, Chen SH, Comfort J, Dona K, Hara N, Haraguchi H, Hsiung YB, Hutcheson M, Inagaki T, Kamiji I, Kawasaki N, Kim EJ, Kim JL, Kim YJ, Ko JW, Komatsubara TK, Kotera K, Kurilin AS, Lee JW, Lim GY, Lin C, Lin Q, Luo Y, Ma J, Maeda Y, Mari T, Masuda T, Matsumura T, Mcfarland D, McNeal N, Micallef J, Miyazaki K, Murayama R, Naito D, Nakagiri K, Nanjo H, Nishimiya H, Nomura T, Ohsugi M, Okuno H, Sasaki M, Sasao N, Sato K, Sato T, Sato Y, Schamis H, Seki S, Shimizu N, Shimogawa T, Shinkawa T, Shinohara S, Shiomi K, Su S, Sugiyama Y, Suzuki S, Tajima Y, Taylor M, Tecchio M, Togawa M, Tung YC, Wah YW, Watanabe H, Woo JK, Yamanaka T, Yoshida HY, KOTO Collaboration. Search for K_L-->pi;0nunu[over ] and K_L-->pi;0X;0 Decays at the J-PARC KOTO Experiment. Phys Rev Lett. 2019 Jan 18; 122 (2):021802
    View PubMed
  19. Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA, PRACTICAL Consortium. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2019 Jan 17; 10 (1):382
    View PubMed
  20. Kamal-Sayed H, Ma J, Tseung H, Abdel-Rehim A, Herman MG, Beltran CJ. Adaptive method for multicriteria optimization of intensity-modulated proton therapy. Med Phys. 2018 Dec; 45 (12):5643-5652 Epub 2018 Nov 08
    View PubMed
  21. Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium. Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2018 Nov 5; 9 (1):4616 Epub 2018 Nov 05
    View PubMed
  22. Ma J, Wan Chan Tseung HS, Herman MG, Beltran C. A robust intensity modulated proton therapy optimizer based on Monte Carlo dose calculation. Med Phys. 2018 Jul 18 Epub 2018 July 18
    View PubMed
  23. J.K. Ahn , J-PARC KOTO Collaboration. A new search for the Klong to pi0 nunubar and Klong to pi0X decays. Prog. Theo. Exp. Phys.. 2017.
  24. Wan Chan Tseung HS, Ma J, Kreofsky CR, Ma DJ, Beltran C. Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2016 Aug 1; 95 (5):1535-1543 Epub 2016 Apr 06
    View PubMed
  25. Masuda T, Ahn JK, Banno S, Campbell M, Comfort J, Duh YT, Hineno T, Hsiung YB, Inagaki T, Iwai E, Kawasaki N, Kim EJ, Kim YJ, Ko JW, Komatsubara TK, Kurilin AS, Lee GH, Lee JW, Lee SK, Lim GY, Ma J, MacFarland D, Maeda Y, Matsumura T, Murayama R, Naito D, Nakaya Y, Nanjo H, Nomura T, Odani Y, Okuno H, Ri YD, Sasao N, Sato K, Sato T, Seki S, Shimogawa T, Shinkawa T, Shiomi K, Son JS, Sugiyama Y, Suzuki S, Tajima Y, Takahashi G, Takashima Y, Tecchio M, Togawa M, Toyoda T, Tung YC, Wah YW, Watanabe H, Woo JK, Xu J, Yamanaka T, Yanagida Y, Yoshida HY, Yoshimoto H. Long-lived neutral-kaon flux measurement for the koto experiment Progress Of Theoretical And Experimental Physics. 2016 Jan; (1)(1)013C03.
  26. Wan Chan Tseung H, Ma J, Beltran C. A fast GPU-based Monte Carlo simulation of proton transport with detailed modeling of nonelastic interactions. Med Phys. 2015 Jun; 42 (6):2967-78
    View PubMed
  27. Ma J, Beltran C, Seum Wan Chan Tseung H, Herman MG. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system. Med Phys. 2014 Dec; 41 (12):121707
    View PubMed
  28. M. Tecchio , J-PARC. The data acquisition system for the KOTO detector Phys. Proc.. 2012.
  29. J. Ma, Y.W. Wah. Searches for Klong to pi0 nu nubar International Journal of Modern Physics E. 2012.
  30. R. Ogata, E391a Collaboration. Study of the Klong to pi0 pi0 nu nubar decay Phys. Rev. D. 2011.
  31. Y.C. Tung, E391a Collaboration. Search for the decay Klong to 3gamma Phys. Rev. D. 2011.
  32. J.K. Ahn, E391a Collaboration. Experimental study of the decay Klong to pi0 nu nubar Phys. Rev. D. 2011.
  33. J. Nix, J. Ma, G.N. Perdue, Y. Zheng, Y.W. Wah. Blind background prediction using a bifurcated analysis scheme Nucl. Instr. Meth. Phys. Res. A. 2010.
  34. Y.C. Tung, E391a Collaboration. Search for a Light Pseudoscalar Particle in the Decay Klong to pi0 pi0 X Phys. Rev. Lett.. 2009.
  35. J.K. Ahn, E391a Collaboration. Search for decay Klong to pi0 nu nubar Phys. Rev. Lett.. 2008.
  36. D. Yu, B.L. Wehrenberg, P. Jha, J. Ma, P. Guyot-Sionnest. Electronic transport of n-type CdSe quantum dot films: Effect of film treatment J. Appl. Phys.. 2006.
  37. B.L. Wehrenberg, D. Yu, J. Ma, P. Guyot-Sionnest. Conduction in charged PbSe nanocrystal films J. Phys. Chem. B. 2005.